100% Quality Guarantee
PhD-Level Technical Support
Key Features

Rat sTREM-2 (soluble Triggering receptor expressed on myeloid cells 2) ELISA Kit (AEFI00988)

SKU AEFI00988
Product Type ELISA Kit
Size 48T/96T
Reactivity Rat
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 18.75 pg/mL
Range 31.25-2000 pg/mL
$857

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Rat sTREM-2 (soluble Triggering receptor expressed on myeloid cells 2) ELISA Kit

The Rat STREM-2 Soluble Triggering Receptor Expressed on Myeloid Cells-2 ELISA Kit is specifically designed for the precise measurement of STREM-2 levels in rat samples including serum, plasma, and cell culture supernatants. This kit offers exceptional sensitivity and specificity, ensuring accurate and consistent results for a variety of research applications. STREM-2, also known as Triggering Receptor Expressed on Myeloid Cells-2, plays a crucial role in immune response and inflammatory processes. Its levels have been implicated in various diseases such as autoimmune disorders, infection, and neuroinflammation, making it a valuable biomarker for understanding these conditions and exploring potential therapeutic interventions.

Overall, the Rat STREM-2 ELISA Kit provides researchers with a reliable tool to study STREM-2 expression and function in rat models, ultimately advancing our understanding of immune-related diseases and potentially leading to the development of novel treatment strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose